{"gene":"USP42","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":2011,"finding":"USP42 forms a direct complex with p53 and deubiquitinates p53, controlling its ubiquitination level during the early phase of the stress response. USP42 is required for rapid activation of p53-dependent transcription and p53-dependent cell-cycle arrest in response to stress, though it does not control basal or fully activated p53 levels.","method":"Co-immunoprecipitation, deubiquitination assays, siRNA knockdown with p53 transcriptional activity and cell-cycle arrest readouts","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct complex demonstrated by Co-IP, deubiquitination activity shown, functional phenotype (p53-dependent transcription and cell-cycle arrest) validated by knockdown, multiple orthogonal methods in single study","pmids":["22085928"],"is_preprint":false},{"year":2014,"finding":"USP42 co-localizes with RNA Polymerase II in nuclear foci, binds histone H2B, and deubiquitinates H2B. Depletion of USP42 increases H2B ubiquitylation at a model promoter and decreases both basal and induced transcription from multiple promoters, indicating a p53-independent role in transcriptional regulation.","method":"Co-immunoprecipitation, deubiquitination assay, chromatin immunoprecipitation, siRNA knockdown with transcription reporter readouts, immunofluorescence co-localization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — binding confirmed by Co-IP, enzymatic activity shown by deubiquitination assay, functional consequence (transcription changes) confirmed by ChIP and reporter assays, multiple orthogonal methods","pmids":["25336640"],"is_preprint":false},{"year":2021,"finding":"USP42 binds to the Dishevelled interacting region (DIR) of ZNRF3, deubiquitinates ZNRF3, and stalls the R-spondin–LGR4–ZNRF3 ternary complex, thereby protecting ZNRF3/RNF43 from R-spondin-dependent membrane clearance. This results in increased turnover of LRP6 and Frizzled receptors and inhibition of Wnt signalling. USP42 functions as a roadblock for paracrine Wnt signalling in colon cancer cells and mouse small intestinal organoids.","method":"Co-immunoprecipitation, deubiquitination assay, siRNA knockdown with Wnt reporter assays, organoid functional assays, receptor turnover assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct binding to ZNRF3 DIR domain shown, deubiquitination activity demonstrated, functional Wnt pathway inhibition confirmed in multiple cellular systems (cancer cells and organoids)","pmids":["33786993"],"is_preprint":false},{"year":2021,"finding":"USP42 localizes to SC35-positive nuclear speckles in a manner dependent on its positively charged C-terminal residues and its enzymatic activity. The disordered C-terminal domain confers liquid-liquid phase separation properties. USP42 directs integration of the spliceosome component PLRG1 into nuclear speckles and its depletion disrupts SC35 foci conformation and causes multiple mRNA splicing defects, leading to impaired cancer cell growth.","method":"Immunofluorescence/co-localization with SC35, phase separation assays, siRNA knockdown with mRNA splicing profiling, C-terminal domain mutagenesis, cancer cell growth assays","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — localization directly demonstrated with functional consequence, phase separation experimentally confirmed, PLRG1 interaction shown, splicing defects and growth phenotype validated with multiple methods","pmids":["33731873"],"is_preprint":false},{"year":2020,"finding":"USP42 localizes to nuclear speckles and promotes homologous recombination (HR) DNA repair by facilitating BRCA1 recruitment to double-strand break (DSB) sites and DNA-end resection. USP42 interacts with the DNA-RNA helicase DHX9 and is required for efficient resolution of DSB-induced R-loops. Nuclear speckle localization of USP42 is required for efficient HR.","method":"siRNA knockdown with HR reporter assay, immunofluorescence for BRCA1 recruitment and DNA-end resection markers, co-immunoprecipitation with DHX9, R-loop detection assay","journal":"Oncogenesis","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional HR defect confirmed by knockdown, BRCA1 recruitment and resection directly measured, DHX9 interaction shown by Co-IP, R-loop resolution functionally demonstrated, multiple orthogonal methods","pmids":["32541651"],"is_preprint":false},{"year":2006,"finding":"Mouse Usp42 encodes a deubiquitinating enzyme that can cleave ubiquitin from ubiquitinated substrates both in vitro and in vivo, as demonstrated by deubiquitinating enzyme assays. The protein contains the conserved catalytic Cys, Asp(I), His, and Asn/Asp(II) domains characteristic of DUBs.","method":"In vitro deubiquitination assay, in vivo ubiquitin cleavage assay","journal":"Gene expression patterns : GEP","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro enzymatic activity confirmed, single lab, no mechanistic detail on substrate specificity or active-site mutagenesis","pmids":["16904385"],"is_preprint":false},{"year":2022,"finding":"USP42 stabilizes TRIM21 by deubiquitinating it in human microglial cells during Japanese Encephalitis Virus infection. Increased USP42 maintains higher cellular levels of both TRIM21 and OAS1. TRIM21, independently of its RING domain, increases USP42 levels in a positive feedback loop.","method":"Co-immunoprecipitation, deubiquitination assay, siRNA knockdown, Western blot, in vitro and in vivo experiments in microglial cells","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — deubiquitination of TRIM21 demonstrated, feedback loop identified, single lab with limited mechanistic depth described in abstract","pmids":["35779335"],"is_preprint":false},{"year":2025,"finding":"USP42 interacts with, deubiquitinates, and stabilizes PPARγ in hepatocytes, increasing PPARγ-target gene expression for proliferative and antioxidative responses. FGF2 induces USP42 expression and enhances the USP42–PPARγ interaction during liver regeneration.","method":"Co-immunoprecipitation, deubiquitination assay, Western blot for PPARγ stability, siRNA knockdown/overexpression in hepatocytes, CCl4 liver injury model","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct interaction and deubiquitination activity shown by Co-IP and deubiquitination assay, functional consequence demonstrated in vivo, single lab","pmids":["40091484"],"is_preprint":false},{"year":2025,"finding":"Androgen receptor (AR) positively regulates USP42 mRNA and protein expression in prostate cancer cells. USP42 inhibition induces significant defects in DNA damage repair and sensitizes prostate cancer cells to olaparib.","method":"Low-androgen medium culture, AR modulation with Western blot/RT-PCR readout, RNA sequencing, proteomics, γ-H2A.X detection, xenograft model","journal":"Frontiers in molecular biosciences","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — AR regulation of USP42 shown by multiple methods, DNA repair role confirmed by γ-H2A.X and olaparib sensitization, single lab","pmids":["40718793"],"is_preprint":false},{"year":2025,"finding":"USP42 knockdown in breast cancer cells increases phosphorylation of JNK and p38, upregulates pro-apoptotic proteins (caspase-3, Bax) and downregulates Bcl-2, leading to increased apoptosis. Pharmacological inhibition of JNK (SP600125) or p38 (SB203580) rescues the apoptosis induced by USP42 silencing, placing USP42 upstream of JNK/p38-mediated apoptosis suppression.","method":"siRNA knockdown, Western blot for JNK/p38 phosphorylation and apoptosis markers, flow cytometry, pathway inhibitor rescue experiments, xenograft model","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — epistatic rescue by pathway inhibitors confirms pathway placement, multiple methods used, single lab","pmids":["41120683"],"is_preprint":false}],"current_model":"USP42 is a deubiquitylating enzyme (DUB) that acts on multiple substrates to regulate distinct cellular processes: it deubiquitinates p53 to enable rapid p53-dependent transcriptional stress responses; deubiquitinates histone H2B to promote transcription; deubiquitinates ZNRF3/RNF43 at the plasma membrane to antagonize R-spondin–Wnt signalling; deubiquitinates TRIM21 and PPARγ to stabilize them; localizes to SC35-positive nuclear speckles via its disordered, phase-separating C-terminal domain to direct PLRG1 integration and mRNA splicing; and promotes homologous recombination repair by facilitating BRCA1 recruitment and DHX9-dependent R-loop resolution at DNA double-strand breaks."},"narrative":{"mechanistic_narrative":"USP42 is a deubiquitylating enzyme (DUB) that regulates diverse nuclear and signalling processes by removing ubiquitin from distinct substrate proteins [PMID:16904385]. In the stress response it forms a direct complex with p53 and deubiquitinates it, enabling rapid p53-dependent transcription and cell-cycle arrest without affecting basal or fully activated p53 levels [PMID:22085928]. Beyond p53, USP42 acts broadly on transcription: it binds and deubiquitinates histone H2B, co-localizes with RNA Polymerase II, and supports both basal and induced transcription from multiple promoters [PMID:25336640]. It localizes to SC35-positive nuclear speckles through a positively charged, disordered C-terminal domain that confers liquid-liquid phase separation, and from this compartment it directs PLRG1 integration into speckles and proper mRNA splicing required for cancer cell growth [PMID:33731873]; speckle localization also underlies a role in homologous recombination repair, where USP42 facilitates BRCA1 recruitment and DNA-end resection and partners with the helicase DHX9 to resolve double-strand-break-induced R-loops [PMID:32541651]. At the plasma membrane USP42 binds the Dishevelled-interacting region of ZNRF3 and deubiquitinates it, stalling the R-spondin–LGR4–ZNRF3 ternary complex to protect ZNRF3/RNF43 and thereby antagonize Wnt signalling in colon cancer cells and intestinal organoids [PMID:33786993]. USP42 additionally stabilizes substrates by deubiquitination in context-specific settings, including TRIM21 during viral infection [PMID:35779335] and PPARγ during liver regeneration [PMID:40091484].","teleology":[{"year":2006,"claim":"Establishing whether USP42 was a bona fide enzyme was the first prerequisite; this showed the protein carries the conserved DUB catalytic residues and can cleave ubiquitin from substrates.","evidence":"in vitro and in vivo deubiquitination assays on mouse Usp42","pmids":["16904385"],"confidence":"Medium","gaps":["No substrate specificity defined","No active-site mutagenesis to confirm catalytic residues","Single lab"]},{"year":2011,"claim":"Identifying the first physiological substrate, this work showed USP42 deubiquitinates p53 specifically during the early stress response, defining a role in timing rapid p53-dependent transcription and cell-cycle arrest.","evidence":"Co-IP, deubiquitination assays, and siRNA knockdown with p53 transcriptional and cell-cycle readouts","pmids":["22085928"],"confidence":"High","gaps":["Does not control basal or fully activated p53 levels","Mechanism of stress-phase selectivity unclear"]},{"year":2014,"claim":"Extending USP42 beyond p53, this established a direct chromatin role: it deubiquitinates histone H2B and supports transcription, indicating a p53-independent function in gene expression.","evidence":"Co-IP, deubiquitination assay, ChIP, transcription reporters, and IF co-localization with RNA Pol II","pmids":["25336640"],"confidence":"High","gaps":["Promoter selectivity not defined","Link between H2B deubiquitination and Pol II co-localization not fully resolved"]},{"year":2020,"claim":"This connected USP42 nuclear speckle localization to genome maintenance, showing it promotes homologous recombination via BRCA1 recruitment, end resection, and DHX9-dependent R-loop resolution at double-strand breaks.","evidence":"HR reporter assay, IF for BRCA1/resection markers, Co-IP with DHX9, and R-loop detection","pmids":["32541651"],"confidence":"High","gaps":["Direct DUB substrate at break sites not identified","Whether DHX9 is a deubiquitination target unknown"]},{"year":2021,"claim":"This defined the structural basis of USP42 nuclear compartmentalization, showing its disordered, charged C-terminus drives phase separation into SC35 speckles to direct PLRG1 integration and mRNA splicing.","evidence":"IF co-localization with SC35, phase separation assays, C-terminal mutagenesis, splicing profiling, and growth assays","pmids":["33731873"],"confidence":"High","gaps":["Whether PLRG1 is a deubiquitination substrate not shown","Splicing targets not mapped"]},{"year":2021,"claim":"This placed USP42 in Wnt receptor regulation, showing it binds the ZNRF3 DIR, deubiquitinates ZNRF3, and stalls the R-spondin ternary complex to antagonize paracrine Wnt signalling.","evidence":"Co-IP, deubiquitination assay, Wnt reporters, receptor turnover assays, and intestinal organoids","pmids":["33786993"],"confidence":"High","gaps":["Plasma membrane vs nuclear pools not reconciled","Selectivity for ZNRF3 vs RNF43 not fully defined"]},{"year":2022,"claim":"This added a substrate-stabilization role in innate immunity, showing USP42 deubiquitinates and stabilizes TRIM21 in a positive feedback loop during viral infection.","evidence":"Co-IP, deubiquitination assay, knockdown, and Western blot in microglial cells with JEV infection","pmids":["35779335"],"confidence":"Medium","gaps":["Mechanism of the feedback loop not detailed","Single lab, limited mechanistic depth"]},{"year":2025,"claim":"This identified PPARγ as a USP42 substrate in liver regeneration, showing USP42 stabilizes PPARγ to drive proliferative and antioxidative gene programs downstream of FGF2.","evidence":"Co-IP, deubiquitination assay, Western blot, knockdown/overexpression in hepatocytes, and CCl4 injury model","pmids":["40091484"],"confidence":"Medium","gaps":["Ubiquitin linkage type on PPARγ not defined","FGF2-to-USP42 signalling axis not resolved"]},{"year":2025,"claim":"This linked USP42 to androgen signalling and DNA repair in prostate cancer, showing AR drives USP42 expression and USP42 inhibition impairs DNA damage repair and sensitizes cells to olaparib.","evidence":"AR modulation, RNA-seq, proteomics, γ-H2A.X detection, and xenograft model","pmids":["40718793"],"confidence":"Medium","gaps":["Direct DUB substrate in this DNA repair context not identified","Relationship to the HR/BRCA1 mechanism not integrated"]},{"year":2025,"claim":"This positioned USP42 as a suppressor of stress-kinase apoptosis in breast cancer, showing its knockdown activates JNK/p38 and pro-apoptotic effectors with rescue by pathway inhibitors.","evidence":"siRNA knockdown, Western blot, flow cytometry, inhibitor rescue (SP600125/SB203580), and xenograft model","pmids":["41120683"],"confidence":"Medium","gaps":["Direct substrate upstream of JNK/p38 not identified","Whether effect is catalytic-dependent untested"]},{"year":null,"claim":"How USP42's multiple substrate-specific functions are coordinated, and what ubiquitin-linkage selectivity and recruitment mechanisms govern each, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of substrate recognition","Linkage specificity across substrates undefined","How nuclear-speckle, chromatin, and membrane pools are partitioned is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2,5,6,7]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[5,0]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[1]}],"localization":[{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[3,4]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[4,8]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,0]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[3]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2]}],"complexes":["SC35 nuclear speckles"],"partners":["TP53","ZNRF3","DHX9","BRCA1","PLRG1","TRIM21","PPARG"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H9J4","full_name":"Ubiquitin carboxyl-terminal hydrolase 42","aliases":["Deubiquitinating enzyme 42","Ubiquitin thioesterase 42","Ubiquitin-specific-processing protease 42"],"length_aa":1324,"mass_kda":145.4,"function":"Deubiquitinating enzyme which may play an important role during spermatogenesis","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q9H9J4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/USP42","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/USP42","total_profiled":1310},"omim":[{"mim_id":"620946","title":"UBIQUITIN-SPECIFIC PEPTIDASE 42; USP42","url":"https://www.omim.org/entry/620946"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nucleoli","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/USP42"},"hgnc":{"alias_symbol":["FLJ12697"],"prev_symbol":[]},"alphafold":{"accession":"Q9H9J4","domains":[{"cath_id":"3.90.70.10","chopping":"102-416","consensus_level":"medium","plddt":93.258,"start":102,"end":416}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H9J4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H9J4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H9J4-F1-predicted_aligned_error_v6.png","plddt_mean":48.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=USP42","jax_strain_url":"https://www.jax.org/strain/search?query=USP42"},"sequence":{"accession":"Q9H9J4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H9J4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H9J4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H9J4"}},"corpus_meta":[{"pmid":"22085928","id":"PMC_22085928","title":"Regulation of p53 stability and function by the deubiquitinating enzyme USP42.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22085928","citation_count":94,"is_preprint":false},{"pmid":"16357831","id":"PMC_16357831","title":"A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42.","date":"2006","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/16357831","citation_count":63,"is_preprint":false},{"pmid":"33731873","id":"PMC_33731873","title":"USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/33731873","citation_count":57,"is_preprint":false},{"pmid":"33786993","id":"PMC_33786993","title":"USP42 protects ZNRF3/RNF43 from R-spondin-dependent clearance and inhibits Wnt signalling.","date":"2021","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/33786993","citation_count":44,"is_preprint":false},{"pmid":"25336640","id":"PMC_25336640","title":"Ubiquitin-specific peptidase 42 (USP42) functions to deubiquitylate histones and regulate transcriptional activity.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25336640","citation_count":39,"is_preprint":false},{"pmid":"32541651","id":"PMC_32541651","title":"USP42 enhances homologous recombination repair by promoting R-loop resolution with a DNA-RNA helicase DHX9.","date":"2020","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/32541651","citation_count":32,"is_preprint":false},{"pmid":"16904385","id":"PMC_16904385","title":"The expression of Usp42 during embryogenesis and spermatogenesis in mouse.","date":"2006","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/16904385","citation_count":27,"is_preprint":false},{"pmid":"35779335","id":"PMC_35779335","title":"Japanese Encephalitis Virus infection increases USP42 to stabilize TRIM21 and OAS1 for neuroinflammatory and anti-viral response in human microglia.","date":"2022","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/35779335","citation_count":12,"is_preprint":false},{"pmid":"25298786","id":"PMC_25298786","title":"5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications.","date":"2014","source":"Molecular cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/25298786","citation_count":11,"is_preprint":false},{"pmid":"40091484","id":"PMC_40091484","title":"FGF2 Mediated USP42-PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/40091484","citation_count":5,"is_preprint":false},{"pmid":"38338801","id":"PMC_38338801","title":"Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38338801","citation_count":2,"is_preprint":false},{"pmid":"40718793","id":"PMC_40718793","title":"Targeting USP42 induces DNA damage and inhibits cell growth in prostate cancer.","date":"2025","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/40718793","citation_count":0,"is_preprint":false},{"pmid":"41120683","id":"PMC_41120683","title":"Deubiquitinating enzyme USP42 promotes breast cancer progression by inhibiting JNK/p38-mediated apoptosis.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41120683","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8090,"output_tokens":2778,"usd":0.03297,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10128,"output_tokens":3598,"usd":0.070295,"stage2_stop_reason":"end_turn"},"total_usd":0.103265,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"USP42 forms a direct complex with p53 and deubiquitinates p53, controlling its ubiquitination level during the early phase of the stress response. USP42 is required for rapid activation of p53-dependent transcription and p53-dependent cell-cycle arrest in response to stress, though it does not control basal or fully activated p53 levels.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitination assays, siRNA knockdown with p53 transcriptional activity and cell-cycle arrest readouts\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct complex demonstrated by Co-IP, deubiquitination activity shown, functional phenotype (p53-dependent transcription and cell-cycle arrest) validated by knockdown, multiple orthogonal methods in single study\",\n      \"pmids\": [\"22085928\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"USP42 co-localizes with RNA Polymerase II in nuclear foci, binds histone H2B, and deubiquitinates H2B. Depletion of USP42 increases H2B ubiquitylation at a model promoter and decreases both basal and induced transcription from multiple promoters, indicating a p53-independent role in transcriptional regulation.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitination assay, chromatin immunoprecipitation, siRNA knockdown with transcription reporter readouts, immunofluorescence co-localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding confirmed by Co-IP, enzymatic activity shown by deubiquitination assay, functional consequence (transcription changes) confirmed by ChIP and reporter assays, multiple orthogonal methods\",\n      \"pmids\": [\"25336640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP42 binds to the Dishevelled interacting region (DIR) of ZNRF3, deubiquitinates ZNRF3, and stalls the R-spondin–LGR4–ZNRF3 ternary complex, thereby protecting ZNRF3/RNF43 from R-spondin-dependent membrane clearance. This results in increased turnover of LRP6 and Frizzled receptors and inhibition of Wnt signalling. USP42 functions as a roadblock for paracrine Wnt signalling in colon cancer cells and mouse small intestinal organoids.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitination assay, siRNA knockdown with Wnt reporter assays, organoid functional assays, receptor turnover assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding to ZNRF3 DIR domain shown, deubiquitination activity demonstrated, functional Wnt pathway inhibition confirmed in multiple cellular systems (cancer cells and organoids)\",\n      \"pmids\": [\"33786993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP42 localizes to SC35-positive nuclear speckles in a manner dependent on its positively charged C-terminal residues and its enzymatic activity. The disordered C-terminal domain confers liquid-liquid phase separation properties. USP42 directs integration of the spliceosome component PLRG1 into nuclear speckles and its depletion disrupts SC35 foci conformation and causes multiple mRNA splicing defects, leading to impaired cancer cell growth.\",\n      \"method\": \"Immunofluorescence/co-localization with SC35, phase separation assays, siRNA knockdown with mRNA splicing profiling, C-terminal domain mutagenesis, cancer cell growth assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — localization directly demonstrated with functional consequence, phase separation experimentally confirmed, PLRG1 interaction shown, splicing defects and growth phenotype validated with multiple methods\",\n      \"pmids\": [\"33731873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"USP42 localizes to nuclear speckles and promotes homologous recombination (HR) DNA repair by facilitating BRCA1 recruitment to double-strand break (DSB) sites and DNA-end resection. USP42 interacts with the DNA-RNA helicase DHX9 and is required for efficient resolution of DSB-induced R-loops. Nuclear speckle localization of USP42 is required for efficient HR.\",\n      \"method\": \"siRNA knockdown with HR reporter assay, immunofluorescence for BRCA1 recruitment and DNA-end resection markers, co-immunoprecipitation with DHX9, R-loop detection assay\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional HR defect confirmed by knockdown, BRCA1 recruitment and resection directly measured, DHX9 interaction shown by Co-IP, R-loop resolution functionally demonstrated, multiple orthogonal methods\",\n      \"pmids\": [\"32541651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Mouse Usp42 encodes a deubiquitinating enzyme that can cleave ubiquitin from ubiquitinated substrates both in vitro and in vivo, as demonstrated by deubiquitinating enzyme assays. The protein contains the conserved catalytic Cys, Asp(I), His, and Asn/Asp(II) domains characteristic of DUBs.\",\n      \"method\": \"In vitro deubiquitination assay, in vivo ubiquitin cleavage assay\",\n      \"journal\": \"Gene expression patterns : GEP\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro enzymatic activity confirmed, single lab, no mechanistic detail on substrate specificity or active-site mutagenesis\",\n      \"pmids\": [\"16904385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"USP42 stabilizes TRIM21 by deubiquitinating it in human microglial cells during Japanese Encephalitis Virus infection. Increased USP42 maintains higher cellular levels of both TRIM21 and OAS1. TRIM21, independently of its RING domain, increases USP42 levels in a positive feedback loop.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitination assay, siRNA knockdown, Western blot, in vitro and in vivo experiments in microglial cells\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — deubiquitination of TRIM21 demonstrated, feedback loop identified, single lab with limited mechanistic depth described in abstract\",\n      \"pmids\": [\"35779335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"USP42 interacts with, deubiquitinates, and stabilizes PPARγ in hepatocytes, increasing PPARγ-target gene expression for proliferative and antioxidative responses. FGF2 induces USP42 expression and enhances the USP42–PPARγ interaction during liver regeneration.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitination assay, Western blot for PPARγ stability, siRNA knockdown/overexpression in hepatocytes, CCl4 liver injury model\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct interaction and deubiquitination activity shown by Co-IP and deubiquitination assay, functional consequence demonstrated in vivo, single lab\",\n      \"pmids\": [\"40091484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Androgen receptor (AR) positively regulates USP42 mRNA and protein expression in prostate cancer cells. USP42 inhibition induces significant defects in DNA damage repair and sensitizes prostate cancer cells to olaparib.\",\n      \"method\": \"Low-androgen medium culture, AR modulation with Western blot/RT-PCR readout, RNA sequencing, proteomics, γ-H2A.X detection, xenograft model\",\n      \"journal\": \"Frontiers in molecular biosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — AR regulation of USP42 shown by multiple methods, DNA repair role confirmed by γ-H2A.X and olaparib sensitization, single lab\",\n      \"pmids\": [\"40718793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"USP42 knockdown in breast cancer cells increases phosphorylation of JNK and p38, upregulates pro-apoptotic proteins (caspase-3, Bax) and downregulates Bcl-2, leading to increased apoptosis. Pharmacological inhibition of JNK (SP600125) or p38 (SB203580) rescues the apoptosis induced by USP42 silencing, placing USP42 upstream of JNK/p38-mediated apoptosis suppression.\",\n      \"method\": \"siRNA knockdown, Western blot for JNK/p38 phosphorylation and apoptosis markers, flow cytometry, pathway inhibitor rescue experiments, xenograft model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — epistatic rescue by pathway inhibitors confirms pathway placement, multiple methods used, single lab\",\n      \"pmids\": [\"41120683\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"USP42 is a deubiquitylating enzyme (DUB) that acts on multiple substrates to regulate distinct cellular processes: it deubiquitinates p53 to enable rapid p53-dependent transcriptional stress responses; deubiquitinates histone H2B to promote transcription; deubiquitinates ZNRF3/RNF43 at the plasma membrane to antagonize R-spondin–Wnt signalling; deubiquitinates TRIM21 and PPARγ to stabilize them; localizes to SC35-positive nuclear speckles via its disordered, phase-separating C-terminal domain to direct PLRG1 integration and mRNA splicing; and promotes homologous recombination repair by facilitating BRCA1 recruitment and DHX9-dependent R-loop resolution at DNA double-strand breaks.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"USP42 is a deubiquitylating enzyme (DUB) that regulates diverse nuclear and signalling processes by removing ubiquitin from distinct substrate proteins [#5]. In the stress response it forms a direct complex with p53 and deubiquitinates it, enabling rapid p53-dependent transcription and cell-cycle arrest without affecting basal or fully activated p53 levels [#0]. Beyond p53, USP42 acts broadly on transcription: it binds and deubiquitinates histone H2B, co-localizes with RNA Polymerase II, and supports both basal and induced transcription from multiple promoters [#1]. It localizes to SC35-positive nuclear speckles through a positively charged, disordered C-terminal domain that confers liquid-liquid phase separation, and from this compartment it directs PLRG1 integration into speckles and proper mRNA splicing required for cancer cell growth [#3]; speckle localization also underlies a role in homologous recombination repair, where USP42 facilitates BRCA1 recruitment and DNA-end resection and partners with the helicase DHX9 to resolve double-strand-break-induced R-loops [#4]. At the plasma membrane USP42 binds the Dishevelled-interacting region of ZNRF3 and deubiquitinates it, stalling the R-spondin–LGR4–ZNRF3 ternary complex to protect ZNRF3/RNF43 and thereby antagonize Wnt signalling in colon cancer cells and intestinal organoids [#2]. USP42 additionally stabilizes substrates by deubiquitination in context-specific settings, including TRIM21 during viral infection [#6] and PPARγ during liver regeneration [#7].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Establishing whether USP42 was a bona fide enzyme was the first prerequisite; this showed the protein carries the conserved DUB catalytic residues and can cleave ubiquitin from substrates.\",\n      \"evidence\": \"in vitro and in vivo deubiquitination assays on mouse Usp42\",\n      \"pmids\": [\"16904385\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No substrate specificity defined\", \"No active-site mutagenesis to confirm catalytic residues\", \"Single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identifying the first physiological substrate, this work showed USP42 deubiquitinates p53 specifically during the early stress response, defining a role in timing rapid p53-dependent transcription and cell-cycle arrest.\",\n      \"evidence\": \"Co-IP, deubiquitination assays, and siRNA knockdown with p53 transcriptional and cell-cycle readouts\",\n      \"pmids\": [\"22085928\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Does not control basal or fully activated p53 levels\", \"Mechanism of stress-phase selectivity unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extending USP42 beyond p53, this established a direct chromatin role: it deubiquitinates histone H2B and supports transcription, indicating a p53-independent function in gene expression.\",\n      \"evidence\": \"Co-IP, deubiquitination assay, ChIP, transcription reporters, and IF co-localization with RNA Pol II\",\n      \"pmids\": [\"25336640\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Promoter selectivity not defined\", \"Link between H2B deubiquitination and Pol II co-localization not fully resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"This connected USP42 nuclear speckle localization to genome maintenance, showing it promotes homologous recombination via BRCA1 recruitment, end resection, and DHX9-dependent R-loop resolution at double-strand breaks.\",\n      \"evidence\": \"HR reporter assay, IF for BRCA1/resection markers, Co-IP with DHX9, and R-loop detection\",\n      \"pmids\": [\"32541651\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct DUB substrate at break sites not identified\", \"Whether DHX9 is a deubiquitination target unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"This defined the structural basis of USP42 nuclear compartmentalization, showing its disordered, charged C-terminus drives phase separation into SC35 speckles to direct PLRG1 integration and mRNA splicing.\",\n      \"evidence\": \"IF co-localization with SC35, phase separation assays, C-terminal mutagenesis, splicing profiling, and growth assays\",\n      \"pmids\": [\"33731873\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Whether PLRG1 is a deubiquitination substrate not shown\", \"Splicing targets not mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"This placed USP42 in Wnt receptor regulation, showing it binds the ZNRF3 DIR, deubiquitinates ZNRF3, and stalls the R-spondin ternary complex to antagonize paracrine Wnt signalling.\",\n      \"evidence\": \"Co-IP, deubiquitination assay, Wnt reporters, receptor turnover assays, and intestinal organoids\",\n      \"pmids\": [\"33786993\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Plasma membrane vs nuclear pools not reconciled\", \"Selectivity for ZNRF3 vs RNF43 not fully defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"This added a substrate-stabilization role in innate immunity, showing USP42 deubiquitinates and stabilizes TRIM21 in a positive feedback loop during viral infection.\",\n      \"evidence\": \"Co-IP, deubiquitination assay, knockdown, and Western blot in microglial cells with JEV infection\",\n      \"pmids\": [\"35779335\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism of the feedback loop not detailed\", \"Single lab, limited mechanistic depth\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"This identified PPARγ as a USP42 substrate in liver regeneration, showing USP42 stabilizes PPARγ to drive proliferative and antioxidative gene programs downstream of FGF2.\",\n      \"evidence\": \"Co-IP, deubiquitination assay, Western blot, knockdown/overexpression in hepatocytes, and CCl4 injury model\",\n      \"pmids\": [\"40091484\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Ubiquitin linkage type on PPARγ not defined\", \"FGF2-to-USP42 signalling axis not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"This linked USP42 to androgen signalling and DNA repair in prostate cancer, showing AR drives USP42 expression and USP42 inhibition impairs DNA damage repair and sensitizes cells to olaparib.\",\n      \"evidence\": \"AR modulation, RNA-seq, proteomics, γ-H2A.X detection, and xenograft model\",\n      \"pmids\": [\"40718793\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct DUB substrate in this DNA repair context not identified\", \"Relationship to the HR/BRCA1 mechanism not integrated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"This positioned USP42 as a suppressor of stress-kinase apoptosis in breast cancer, showing its knockdown activates JNK/p38 and pro-apoptotic effectors with rescue by pathway inhibitors.\",\n      \"evidence\": \"siRNA knockdown, Western blot, flow cytometry, inhibitor rescue (SP600125/SB203580), and xenograft model\",\n      \"pmids\": [\"41120683\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct substrate upstream of JNK/p38 not identified\", \"Whether effect is catalytic-dependent untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How USP42's multiple substrate-specific functions are coordinated, and what ubiquitin-linkage selectivity and recruitment mechanisms govern each, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No structural model of substrate recognition\", \"Linkage specificity across substrates undefined\", \"How nuclear-speckle, chromatin, and membrane pools are partitioned is unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2, 5, 6, 7]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [5, 0]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [4, 8]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 0]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [\"SC35 nuclear speckles\"],\n    \"partners\": [\"TP53\", \"ZNRF3\", \"DHX9\", \"BRCA1\", \"PLRG1\", \"TRIM21\", \"PPARG\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}